erlotinib hydrochloride has been researched along with Nephritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batlle, D; Egido, J; Eguchi, S; Keri, G; Morgado-Pascual, JL; Ortiz, A; Pato, J; Ramos, AM; Rayego-Mateos, S; Ruiz-Ortega, M; Sanz, AB | 1 |
1 other study(ies) available for erlotinib hydrochloride and Nephritis
Article | Year |
---|---|
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Cells, Cultured; Cytokine TWEAK; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Silencing; Heparin-binding EGF-like Growth Factor; Humans; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Kidney Tubules; Ligands; Mice; Mice, Inbred C57BL; Nephritis; NF-kappa B; Phosphorylation; Quinazolines; Receptors, Tumor Necrosis Factor; Signal Transduction; Transcriptional Activation; Transforming Growth Factor alpha; Tumor Necrosis Factors; TWEAK Receptor | 2013 |